4
Changes in Ownership
Candel Therapeutics, Inc. Filed Acc 0001193125-26-412654
Options or other derivatives
- Director acquired 2,189 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Manning Paul B · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-30 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +2,189 | $8.68 | $18,992 | 2,189 | D |
Loading xslF345X06/ownership.xml…